To Evaluate the Safety of Duloxetine in Patients With Stress Urinary Incontinence

PHASE3CompletedINTERVENTIONAL
Enrollment

600

Participants

Timeline

Start Date

February 28, 2001

Study Completion Date

May 31, 2006

Conditions
Stress Urinary Incontinence
Interventions
DRUG

Duloxetine

Trial Locations (2)

80220

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician, Denver

L6H3P1

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559,1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician, Oakville

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Boehringer Ingelheim

INDUSTRY

lead

Eli Lilly and Company

INDUSTRY